logo
Rupert Resources Announces Annual Meeting Voting Results

Rupert Resources Announces Annual Meeting Voting Results

Business Wire17 hours ago

TORONTO--(BUSINESS WIRE)--Rupert Resources Ltd. (' Rupert Resources ' or the ' Company ') announces the voting results from the 2025 Annual Meeting.
The nine nominees listed in its management information circular (the ' Circular ') dated May 26, 2025 were elected as directors at the Annual Meeting of Shareholders of Rupert Resources (the ' Meeting '). Carol Plummer will now join the board of directors as a nominee for Agnico Eagle, one of the Company's largest shareholders. Carol is currently the Executive Vice President, Sustainability, People & Culture at Agnico Eagle, and has extensive operating experience, including in Finland, where she was previously the General Manager of Agnico Eagle's Kittilä mine. Carol was also recently appointed Chair of the Mining Association of Canada.
Gunnar Nilsson, Non-Executive Chairman of Rupert Resources said:
'We appreciate the support of shareholders in passing all resolutions at the 2025 annual meeting. We are also very pleased to welcome Carol Plummer to the Board. Her operational experience in Finland will be a valuable addition to the diverse skill set offered by the existing non-executive directors.'
There were 121,850,560 common shares represented in person or by proxy at the Meeting (representing 52.06% of the issued and outstanding common shares of the Corporation being 234,056,848 as of the record date for the Meeting). The voting results for the Meeting are set out below.
At the Meeting, the following resolutions as set out in the Circular, were passed as ordinary resolutions of Rupert's shareholders. Proxies and votes received at the Meeting were as follows:
Election of Directors:
DIRECTOR
FOR
WITHHELD
Gunnar Nilsson
118,320,785
99.95%
64,794
0.05%
Michael Ouellette
112,107,574
94.70%
6,278,005
5.30%
Andre Lauzon
117,247,131
99.04%
1,138,448
0.96%
William Washington
117,251,531
99.04%
1,134,048
0.96%
Riikka Aaltonen
118,313,885
99.94%
71,694
0.06%
Graham Crew
118,317,885
99.94%
67,694
0.06%
Carol Plummer
118,312,585
99.94%
72,994
0.06%
Joanna Pearson
118,312,585
99.94%
72,994
0.06%
Kim Hagberg
118,311,085
99.94%
74,494
0.06%
Expand
Appointment of Auditors:
An ordinary resolution to appoint MNP LLP to serve as the independent auditors of the Corporation and authorizing the directors of the Corporation to fix the auditors' remuneration was also approved by ballot.
Based on proxies and votes received at the Meeting, 121,796,111 common shares (approximately 99.96%) voted 'for', and 54,449 common shares (approximately 0.04%) 'withheld'.
Article Amendments:
A Special Resolution adopting certain amendments to the existing articles of the Company, in order to make certain necessary changes required in connection with the Company's graduation to the TSX and certain other housekeeping amendments (collectively, the ' Article Amendments '. The details of the Article Amendments were set out in Schedule C of the Management Information Circular dated May 26, 2025.
Based on proxies and votes received at the Meeting, 112,042,314 common shares (approximately 94.64%) voted 'for', and 6,343,265 common shares (approximately 5.36%) 'against'.
Amendments to Equity Incentive Plan and Renewal of Unallocated Entitlements Thereunder:
An ordinary resolution for amendments to the Company's amended and restated equity incentive plan dated November 9, 2022 (the ' Equity Incentive Plan '), as set out in Schedule D of the Management Information Circular (collectively, the ' Equity Incentive Plan Amendments '), the details of which were set out in Schedule 'D' of the Company's Management Information Circular dated May 26, 2025, together with renewal of unallocated entitlements to continue granting stock options, performance share units and restricted share units under the Plan until June 25, 2028 (collectively, the ' Entitlement Renewals ').
Based on proxies and votes received at the Meeting, 115,652,408 common shares (approximately 97.69%) voted 'for', and 2,733,171 common shares (approximately 2.31%) 'against'.
The results of the matters considered at the Meeting are reported in the Report of Voting Results as filed under the Company's issuer profile on SEDAR+ (www.sedarplus.ca) on June 25, 2025.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset

USA Today

time31 minutes ago

  • USA Today

Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset

Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value Jaguar Health, Inc. ( NASDAQ:JAGX ) ('Jaguar' or 'the Company'), announced today that its Board of Directors has unanimously authorized the Company to include cryptocurrency as a treasury reserve asset. 'Cryptocurrencies continue to gain investor attention and acceptance as a major asset class. We believe selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, diversifying our assets to include a digital store of value that we believe has significant upside potential and may also provide a safeguard against inflation,' said Lisa Conte, Jaguar's Founder and CEO. 'Jaguar has been approached by several banks and an investor with terms for cryptocurrency transactions. The Company is assessing the potential value to shareholders, and the potential benefits for our core development programs, of making selected cryptocurrencies a treasury reserve asset for the Company.' Jaguar's has three core development programs for crofelemer, the Company's novel plant-based prescription medicine: its orphan disease intestinal failure program; its ongoing efforts to make crofelemer available for treatment of cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapies; and its ongoing development program to expand access for Canalevia® (crofelemer delayed-release tablets) in dogs from the conditional approval in chemotherapy-induced diarrhea to a potential global approval for acute general diarrhea. Each of these core programs for crofelemer is the subject of business development goals of forging corporate partnerships to bring in non-dilutive funding for the Company. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute 'forward-looking statements.' These include statements regarding making selected cryptocurrencies a treasury reserve asset for the Company, Jaguar's belief that selected cryptocurrencies could serve as a strong treasury reserve asset for the Company, Jaguar's belief that there may be significant upside potential in diversifying the Company's assets to include a digital store of value, Jaguar's belief that diversifying the Company's assets to include a digital store of value may provide a safeguard against inflation, the potential value to shareholders of making selected cryptocurrencies a treasury reserve asset for the Company, and the potential benefits for Jaguar's core development programs of making selected cryptocurrencies a treasury reserve asset for the some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'aim,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. CONTACT: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc. View the original press release on ACCESS Newswire

New Era Helium Strengthens Board with Strategic Appointments to Support AI Infrastructure Expansion
New Era Helium Strengthens Board with Strategic Appointments to Support AI Infrastructure Expansion

Business Wire

time41 minutes ago

  • Business Wire

New Era Helium Strengthens Board with Strategic Appointments to Support AI Infrastructure Expansion

MIDLAND, Texas--(BUSINESS WIRE)--New Era Helium, Inc. (Nasdaq: NEHC) ('NEH' or the 'Company'), a next-gen exploration and production platform in the Permian Basin, is pleased to announce the appointment of three new board members whose expertise spans digital infrastructure, energy markets, and capital formation. These additions reflect NEH's commitment to building a leadership team equipped to guide the Company through its next phase of growth in the Permian Basin. The new board members include: Trent Yang is a recognized leader in the renewable energy space, having been an investor, entrepreneur and executive in the sustainability industry since 2006. From January 2020 to April 2025 he was the Co-Founder and President of Galway Sustainable Capital a specialty finance company focused on sustainability projects, where he co-managed the business and oversaw the investment team. In 4+ years, Galway raised nearly $700M of institutional capital including Macquarie Asset Management, OakTree and Aware Super. Prior to that, from January 2013 to December 2019, he was a Vice President at AMG National Trust where he oversaw sustainability and international private equity investments. Trent has been investing into and starting sustainability companies since 2006. During that period, he has led investments and/or grown several billion $+ companies including investment firms and renewable companies. He has unique experience investing and growing variety of sustainability platforms including renewable energy & storage, green buildings and data centers, mobility, sustainable agriculture and next generation manufacturing & recycling solutions. He also sits on a number of non-profit boards at the nexus of public policy, education and sustainability. Mr. Yang holds a B.S. in Aerospace Engineering from the University of Colorado, Boulder, and multiple M.S. degrees from Massachusetts Institute of Technology where he focused on climate & economics, machine learning control systems, and entrepreneurship. Peter ('P.J.') Lee is Co-Founder and Managing Partner of EverStream Energy Capital Management LLC, a global investment firm that invests in sustainable energy and digital infrastructure companies and assets worldwide. He has held that role since January 2012. Among other things, his duties include raising funds, sourcing and managing investments. Mr Lee has cofounded several energy company platforms including Terraform Power, TerraForm Global, Pacific Solar (Japan) and Enfinity Global. Mr Lee also cofounded a digital infrastructure company that developed approximately 700 megawatts of data center capacity customized for Bitcoin mining in west Texas, Nebraska and South Dakota. Mr Lee serves as an advisor and Board Director to Engineered Products and PDU Cables which specialize in quick turn, custom assembly electrical products for the data center industry. Mr. Lee previously held leadership positions with investment firm Black River, a division of Cargill, Inc; as well as investment banking firms CE Unterberg Towbin, Robertson Stephens, and Chase Manhattan. Most of Mr Lee's finance career has focused on sectors within the energy, technology, infrastructure, commodity, and digital industries. Mr. Lee holds a bachelor's degree in Economics from Union College. Ondrej Sestak is a Co-Founder and Head of Engineering at ZeroSix LLC, a carbon credit solution provider, since January 2022. He is also a Reservoir Engineer with Aurivos Permian LLC, an oil and gas operator, a position he has held since January 2022. Since January 2022, he has also been a Reservoir Engineer with ARB Energy Utah LLC. He is also Chief Operations Officer for GLT Trading LLC, an international commodities trader, a position he has held since April 2020. As of March 2025, he has also been Project Manager for Five Star Clean Fuels, a strategic developer, owner and operator of distributed gasoline production facilities. Mr. Sestak has over a decade of technical experience across the resource industry. In his role at ZeroSix he is leading the development and implementation of novel methodologies for economic adoption of environmental optimization across the oil and gas industry, including the remediation of marginal operations, responsibly sourced gas, and repurposing of existing wellbores. As Chief Operations Officer for GLT Trading, he sources Helium, LPG, and petcoke on behalf of Asian clients, securing take away agreements from established suppliers, sourcing spot loads on the open market, and pursuing several direct Helium development opportunities. As a reservoir engineer, he is able to evaluate the geologic resource potential as well as the financial viability of producing and development operations. Before moving into his current roles, he worked with INEXS, a petroleum engineering geoscience consulting firm, cultivating unique investment opportunities and performing evaluations of resource projects, including Helium development, blue hydrogen generation, enhanced oil recovery, and carbon capture and utilization. Prior to venturing into the independent investment and operator space of the resource industry, Mr. Sestak was a reservoir engineer at Shell where he worked the Haynesville shale and Vaca Muerta basin. Mr. Sestak holds a B.S. in Petroleum Engineering from the University of Texas at Austin, and an MS in Energy Resource Engineering from Stanford University. E. Will Gray II, CEO of New Era Helium, Inc. commented: 'These appointments are being made to fill vacancies on the board of directors, created by the recent resignations, and reflect NEH's commitment to building a leadership team equipped to guide the Company through its next phase of growth in the Permian Basin.' About New Era Helium, Inc. New Era Helium, Inc. is a next-gen exploration and production platform unlocking the full value of its Permian Basin assets. The Company controls over 137,000 acres in Southeast New Mexico, with more than 1.5 Bcf of proved and probable helium reserves sourced alongside natural gas production. Through its joint venture, Texas Critical Data Centers, LLC, NEHC is capturing multi-sector growth across helium, power, and data infrastructure. For more information, visit Follow New Era Helium on LinkedIn and X. Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements.' Forward-looking statements reflect the current view about future events. When used in this press release, the words 'anticipate,' 'believe,' 'estimate,' 'expect,' 'future,' 'intend,' 'plan' or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation: (a) our ability to effectively operate our business segments; (b) our ability to manage our research, development, expansion, growth and operating expenses; (c) our ability to evaluate and measure our business, prospects and performance metrics; (d) our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry; (e) our ability to respond and adapt to changes in technology and customer behavior; (f) our ability to protect our intellectual property and to develop, maintain and enhance a strong brand; and (g) other factors (including the risks contained in the 'Risk Factors' section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Lifeward prices 4M shares at 65c in public offering
Lifeward prices 4M shares at 65c in public offering

Yahoo

timean hour ago

  • Yahoo

Lifeward prices 4M shares at 65c in public offering

Lifeward (LFWD) announced the pricing of a public offering of an aggregate of 4,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company's ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant. The ordinary warrants will have an exercise price of $0.65 per ordinary share, will be exercisable immediately upon issuance and will expire on the five-year anniversary of the issuance date. The closing of the offering is expected to occur on or about June 26, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.6M before deducting the placement agent's fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the ordinary warrants, if fully exercised on a cash basis, will be approximately $2.6M. The Company intends to use the net proceeds from this offering for its continuing commercial efforts, working capital and general corporate purposes. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on LFWD: Disclaimer & DisclosureReport an Issue Lifeward Announces Annual Meeting Date for 2025 Lifeward Announces New CEO Appointment Effective June 2025 Lifeward appoints Grant as new President, CEO Lifeward Ltd. Reports Q1 2025 Financial Results Lifeward Inc. Earnings Call: Optimism Amid Challenges

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store